Literature DB >> 15240590

Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?

Daniel F Gunther1, Isabelle Bourdeau, Ludmila Matyakhina, David Cassarino, David E Kleiner, Kurt Griffin, Nickolas Courkoutsakis, Mones Abu-Asab, Maria Tsokos, Meg Keil, J Aidan Carney, Constantine A Stratakis.   

Abstract

Cushing syndrome is uncommon in childhood and rare in infancy. We report the case of a 3-yr-old child who presented with symptoms of Cushing syndrome beginning shortly after birth. Her hypercortisolemia was cyclical, causing relapsing and remitting symptoms, which eventually led to suspicions of possible Munchausen syndrome by proxy. Investigation at the National Institutes of Health excluded exogenous administration of glucocorticoids and indicated ACTH-independent Cushing syndrome. Paradoxical response to dexamethasone stimulation (Liddle's test) suggested a diagnosis of primary pigmented nodular adrenocortical disease (PPNAD). After bilateral adrenalectomy, both glands showed micronodular adrenocortical hyperplasia, but histology was not consistent with typical PPNAD. DNA analysis of the coding sequences of the PRKAR1A gene (associated with PPNAD and Carney complex) and the GNAS gene (associated with McCune-Albright syndrome) showed no mutations. We conclude that hypercortisolemia in infancy may be caused by micronodular adrenocortical hyperplasia, which can be cyclical and confused with exogenous Cushing syndrome. A paradoxical rise of glucocorticoid excretion during Liddle's test may delineate these patients. Infantile micronodular disease has some features of PPNAD and may represent its early form; however, at least in the case of the patient reported here, micronodular hyperplasia was not caused by coding mutations of the PRKAR1A or GNAS genes or associated with typical histology or any other features of Carney complex or McCune-Albright syndrome and may represent a distinct entity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240590     DOI: 10.1210/jc.2003-032247

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Children with Cushing's syndrome: Primary Pigmented Nodular Adrenocortical Disease should always be suspected.

Authors:  Renata Marques Gonçalves da Silva; Emília Pinto; Suzan M Goldman; Cássio Andreoni; Teresa C Vieira; Julio Abucham
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

Review 2.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

3.  Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.

Authors:  Anélia Horvath; Jérôme Bertherat; Lionel Groussin; Marine Guillaud-Bataille; Kitman Tsang; Laure Cazabat; Rosella Libé; Elaine Remmers; Fernande René-Corail; Fabio Rueda Faucz; Eric Clauser; Alain Calender; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

4.  Management of Cushing syndrome in children and adolescents: experience of a single tertiary centre.

Authors:  Maria Güemes; Philip G Murray; Caroline E Brain; Helen A Spoudeas; Catherine J Peters; Peter C Hindmarsh; Mehul T Dattani
Journal:  Eur J Pediatr       Date:  2016-05-12       Impact factor: 3.183

Review 5.  Diagnosis and Clinical Genetics of Cushing Syndrome in Pediatrics.

Authors:  Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2016-06       Impact factor: 4.741

Review 6.  Cushing syndrome in pediatrics.

Authors:  Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2012-09-27       Impact factor: 4.741

Review 7.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

8.  Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.

Authors:  Zonggao Shi; Maria J Henwood; Peter Bannerman; Dalia Batista; Anelia Horvath; Marta Guttenberg; Constantine A Stratakis; Adda Grimberg
Journal:  Growth Horm IGF Res       Date:  2007-02-05       Impact factor: 2.372

9.  The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias.

Authors:  Yunze Xu; Wenbin Rui; Yicheng Qi; Chongyu Zhang; Juping Zhao; Xiaojing Wang; Yuxuan Wu; Qi Zhu; Zhoujun Shen; Guang Ning; Yu Zhu
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

10.  Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.

Authors:  S A Boikos; A Horvath; S Heyerdahl; E Stein; A Robinson-White; I Bossis; J Bertherat; J A Carney; C A Stratakis
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.